Reuters logo
10 months ago
BRIEF-Redhill Biopharma provides progress update on RHB-104 Phase III crohn's disease program
October 6, 2016 / 11:37 AM / 10 months ago

BRIEF-Redhill Biopharma provides progress update on RHB-104 Phase III crohn's disease program

Oct 6 (Reuters) - Redhill Biopharma Ltd :

* Redhill Biopharma provides progress update on RHB104 Phase III crohn's disease program and introduces option for early stop for success in Q2/2017

* Independent safety-focused DSMB meeting for Phase III map US study is on track for Q4 of 2016

* Redhill will remain blinded to interim and ongoing results from Phase III study

* An independent safety-focused DSMB meeting for Phase III map US study is on track for Q4 of 2016

* No changes are planned to map US Phase III study's primary endpoint or 90% power Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below